Source: Business Wire

Press Release: Glaukos : Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of Over 30% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery, Target, Product and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering. The Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market was valued at $144 million in 2016, and is expected to reach $912 million by 2023, registering a CAGR of 30.1% from 2017 to 2023. Minimally invasive glaucoma surgery (MIGS) devi

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Thomas W Burns's photo - President & CEO of Glaukos

President & CEO

Thomas W Burns

CEO Approval Rating

88/100

Glaukos is an ophthalmic medical device firm that creates micro invasive glaucoma surgery options for patients. Read more